000 01179nam a2200337 a 4500
005 20250914130116.0
008 030709s2003 xxka b 001 0 eng b
020 _a1841842265
_cRM527.67
039 9 _a200311041030
_bzaleha
_c200309181008
_dzaleha
_y07-09-2003
_zdiyana
060 _aWL360
090 _aWL360.M9596 2003
245 0 0 _aMultiple sclerosis therapeutics /
_cedited by Jeffrey A. Cohen, Richard A. Rudick ; prefaces written by Henry McFarland
250 _a2nd ed.
260 _aLondon :
_bMartin Dunitz,
_c2003
300 _axxiii, 754 p. :
_bill. ;
_c26 cm.
500 _aPrevious ed. : 1999
650 2 _aMultiple Sclerosis
_xtherapy
650 2 _aMultiple Sclerosis
_xpathology
650 2 _aClinical trials
_xMethods
650 2 _aOutcome assessment (Health care)
650 2 _aMagnetic Resonance Imaging
700 1 _aCohen, Jeffrey A.
_q(Jeffrey Alan),
_d1954-
700 1 _aRudick, Richard A.
907 _a.b13217793
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kWL360.M9596 2003
914 _avtls000335965
990 _azh
991 _aJabatan Perubatan, HUKM
998 _ah
_b2003-09-07
_cm
_da
_feng
_gxxk
_y0
_z.b13217793
999 _c321328
_d321328